Christian Bryant

1.4k total citations
36 papers, 992 citations indexed

About

Christian Bryant is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Christian Bryant has authored 36 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 16 papers in Oncology and 15 papers in Immunology. Recurrent topics in Christian Bryant's work include CAR-T cell therapy research (12 papers), Multiple Myeloma Research and Treatments (11 papers) and Immunotherapy and Immune Responses (11 papers). Christian Bryant is often cited by papers focused on CAR-T cell therapy research (12 papers), Multiple Myeloma Research and Treatments (11 papers) and Immunotherapy and Immune Responses (11 papers). Christian Bryant collaborates with scholars based in Australia, United States and Belgium. Christian Bryant's co-authors include John Gibson, Derek N.J. Hart, P. Joy Ho, Phillip D. Fromm, Douglas Joshua, Kieron Rooney, Ross Brown, Hayley Suen, Katharine Steinbeck and Helen O’Connor and has published in prestigious journals such as Blood, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Christian Bryant

32 papers receiving 978 citations

Peers

Christian Bryant
David Bastian United States
Pervinder Sagoo United Kingdom
Teresina Laragione United States
Luisa Cimmino United States
Rachael M. Lane Australia
T E Hugli United States
Christian Bryant
Citations per year, relative to Christian Bryant Christian Bryant (= 1×) peers Panagiotis Tsapogas

Countries citing papers authored by Christian Bryant

Since Specialization
Citations

This map shows the geographic impact of Christian Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Bryant more than expected).

Fields of papers citing papers by Christian Bryant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Bryant. The network helps show where Christian Bryant may publish in the future.

Co-authorship network of co-authors of Christian Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Bryant. A scholar is included among the top collaborators of Christian Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Bryant. Christian Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abadir, Edward, Sachin Gupta, James Favaloro, et al.. (2025). Reduced Chimeric Antigen Receptor T Cell Expansion Postinfusion Is Associated with Poor Survival in Patients with Large B Cell Lymphoma after Two or More Therapies. Transplantation and Cellular Therapy. 31(3). 159–165. 3 indexed citations
2.
Brown, Christina, Christian Bryant, Scott Dunkley, et al.. (2025). Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma—importance of pre-CAR-T optimization. Frontiers in Oncology. 15. 1633644–1633644.
3.
Bryant, Christian, Dipti Talaulikar, Adam Bryant, et al.. (2024). A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies. European Journal Of Haematology. 113(4). 521–529.
5.
Dickinson, Michael, Nada Hamad, Christian Bryant, et al.. (2023). S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES. HemaSphere. 7(S3). e37234fb–e37234fb. 7 indexed citations
6.
Dickinson, Michael, Nada Hamad, Christian Bryant, et al.. (2023). First in human data of NKX019, an allogeneic CAR NK for the treatment of relapsed/refractory (R/R) B‐cell malignancies. Hematological Oncology. 41(S2). 526–527. 8 indexed citations
7.
Lindsay, Julian, Jad Othman, Sebastiaan J. van Hal, et al.. (2021). SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation. Open Forum Infectious Diseases. 8(11). ofab502–ofab502. 11 indexed citations
8.
Dickinson, Michael, Nada Hamad, Christian Bryant, et al.. (2021). A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies. Blood. 138(Supplement 1). 3868–3868. 16 indexed citations
9.
Joshua, Douglas, Slavica Vučković, James Favaloro, et al.. (2021). Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma. Frontiers in Immunology. 12. 620596–620596. 14 indexed citations
10.
Li, Ziduo, Edward Abadir, Candice Clarke, et al.. (2020). Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody. Clinical & Translational Immunology. 9(7). e1156–e1156. 3 indexed citations
11.
Abadir, Edward, Christian Bryant, Stephen Larsen, & Georgina J. Clark. (2019). Targeting the niche: depleting haemopoietic stem cells with targeted therapy. Bone Marrow Transplantation. 54(7). 961–968. 8 indexed citations
12.
Joshua, Douglas, et al.. (2019). Biology and therapy of multiple myeloma. The Medical Journal of Australia. 210(8). 375–380. 89 indexed citations
13.
Bryant, Christian, et al.. (2018). Dendritic cells as cancer therapeutics. Seminars in Cell and Developmental Biology. 86. 77–88. 50 indexed citations
14.
15.
Joshua, Douglas, Hayley Suen, Ross Brown, et al.. (2016). The T Cell in Myeloma. Clinical Lymphoma Myeloma & Leukemia. 16(10). 537–542. 42 indexed citations
16.
Anguille, Sébastien, Evelien Smits, Christian Bryant, et al.. (2015). Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews. 67(4). 731–753. 122 indexed citations
17.
Cheng, Hoi Lun, Christian Bryant, Kieron Rooney, et al.. (2013). Iron, Hepcidin and Inflammatory Status of Young Healthy Overweight and Obese Women in Australia. PLoS ONE. 8(7). e68675–e68675. 35 indexed citations
18.
Cheng, Hoi Lun, Christian Bryant, Rebecca Cook, et al.. (2011). The relationship between obesity and hypoferraemia in adults: a systematic review. Obesity Reviews. 13(2). 150–161. 123 indexed citations
19.
Hammond, R. A., Robert Hannon, Stephen P. Frean, et al.. (1999). Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. American Journal of Veterinary Research. 60(4). 426–431. 46 indexed citations
20.
Ridger, Victoria, E. R. Pettipher, Christian Bryant, & Susan D. Brain. (1997). Effect of the inducible nitric oxide synthase inhibitors aminoguanidine and L-N6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skin. The Journal of Immunology. 159(1). 383–390. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026